Silbis Pharma Private Limited
About Silbis Pharma Private Limited
Data last updated:
Silbis Pharma Private Limited is a private limited company based in Bhubaneswar, Odisha, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51100OR2019PTC032345. Its GSTIN is 21ABDCS1409G1ZW (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Bishnu Prasad Panda and Biswajit Swain.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No.2377 Near Hotel Castle, Bhubaneswar, Odisha, India – 751002.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.24 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹1.21 Lakh (net margin 1%) and EBITDA of ₹1.76 Lakh (EBITDA margin 1.4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.2377 Near Hotel Castle, Bhubaneswar, Odisha, India – 751002
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Silbis Pharma Private Limited
The main business activity of Silbis Pharma is hospital and medical care. In detail, this covers hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Silbis Pharma Private Limited FY 2023 filings available
Silbis Pharma Private Limited reported revenue of ₹1.24 Cr (up 13% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Silbis Pharma Private Limited
Revenue rose 13% in the latest year. EBITDA rose 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Silbis Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.76 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.21 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Silbis Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.4% | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Silbis Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Silbis Pharma Private Limited
Silbis Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bishnu Prasad Panda | Director | 25 Dec 2019 | 6 Years 9 Months | Current |
| Biswajit Swain | Director | 25 Dec 2019 | 6 Years 9 Months | Current |
| Sanjaya Kumar Sil | Director | 25 Dec 2019 | 6 Years 9 Months | Current |
Peer Comparison of Silbis Pharma Private Limited
Silbis Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aveta Meditech (OPC) Private Limited | ₹1.24 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Pune, Maharashtra, India |
| Evestin Healthcare Private Limited | ₹1.24 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Nagpur, Maharashtra, India |
| Chicky Pharma Private Limited | ₹1.24 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Ranchi, Jharkhand, India |
| Aarone Bioginie Private Limited | ₹1.24 Cr (FY 2025) | •••• | •••• | 148.0% | •••• | Delhi, India |
| Merz Bioceuticals Private Limited | ₹1.24 Cr (FY 2025) | •••• | •••• | -36.0% | •••• | Panipat, Haryana, India |
| Silbis Pharma Private Limited this company | ₹1.24 Cr (FY 2023) | •••• | •••• | 13.0% | •••• | Bhubaneswar, Odisha, India |
| Mehta Agencies Private Limited | ₹1.23 Cr (FY 2024) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Clabert Lifesciences Private Limited | ₹1.23 Cr (FY 2024) | •••• | •••• | -26.0% | •••• | Chandigarh, India |
| Agaram Pharmacy Private Limited | ₹1.23 Cr (FY 2025) | •••• | •••• | -46.0% | •••• | Coimbatore, Tamil Nadu, India |
| Asarva Lifesciences Private Limited | ₹1.23 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | New Delhi, Delhi, India |
| Biosafe Lifecare Private Limited | ₹1.23 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Silbis Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Silbis Pharma Private Limited
Silbis Pharma Private Limited is audited by G CHOUDHURY AND CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G CHOUDHURY AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Silbis Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Silbis Pharma Private Limited
Silbis Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Silbis Pharma Private Limited
Employment history and EPFO contributions of people linked to Silbis Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Silbis Pharma Private Limited
Silbis Pharma Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Bibhu Prasad Panigrahi ceased to be Director on 10 Feb 2020.
Credit Ratings, Litigation & Regulatory Alerts for Silbis Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Silbis Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Silbis Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Silbis Pharma Private Limited
Silbis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21ABDCS1409G1ZW | Odisha | Active | 23 Mar 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Silbis Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Silbis Pharma Private Limited
Silbis Pharma is an active private limited company based in Bhubaneswar, Odisha, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 December 2019 (7+ years old) and is registered under CIN U51100OR2019PTC032345.
Silbis Pharma reported revenue of ₹1.24 Cr for FY 2023 (up 13% YoY).
Silbis Pharma has 3 current directors:
- Bishnu Prasad Panda - Director
- Biswajit Swain - Director
- Sanjaya Kumar Sil - Director
Silbis Pharma reported a net profit of ₹1.21 Lakh (net margin 1%) and EBITDA of ₹1.76 Lakh (EBITDA margin 1.4%) for FY 2023, as per its filed financial statements.
The GSTIN of Silbis Pharma is 21ABDCS1409G1ZW, registered in Odisha.
The CIN (Corporate Identification Number) of Silbis Pharma is U51100OR2019PTC032345. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Silbis Pharma was incorporated on 25 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Silbis Pharma by revenue are Aveta Meditech (OPC) Private Limited, Evestin Healthcare Private Limited, Chicky Pharma Private Limited, Aarone Bioginie Private Limited, Merz Bioceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Bibhu Prasad Panigrahi ceased to be Director on 10 Feb 2020. Bishnu Prasad Panda was appointed as Director on 25 Dec 2019. Biswajit Swain was appointed as Director on 25 Dec 2019. Silbis Pharma has 4 board changes on record in total.
The registered office of Silbis Pharma is at Plot No.2377 Near Hotel Castle, Bhubaneswar, Odisha, India – 751002.
Silbis Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.